This book investigates the complex mechanisms underlying therapeutic resistance to anti-hormonal drugs in breast cancer. Authored by Stephen Hiscox, a recognized researcher in the field, this work synthesizes current scientific literature and presents novel insights into the molecular pathways that enable cancer cells to evade treatment. It examines the interplay of genetic mutations, cellular signaling, and the tumor microenvironment in fostering resistance, offering a comprehensive overview of the challenges in overcoming this critical clinical problem.

This book is recognized as a significant contribution to the understanding of endocrine resistance in breast cancer, drawing on extensive research and clinical observations. It is likely to be of interest to oncologists, researchers, and advanced students in oncology and pharmacology. The work provides a detailed and current overview of a complex and critical area of cancer treatment.